Edition:
United States

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

4.84USD
10:27am EST
Change (% chg)

-- (+0.00%)
Prev Close
$4.84
Open
$4.83
Day's High
$4.84
Day's Low
$4.74
Volume
9,344
Avg. Vol
121,923
52-wk High
$36.93
52-wk Low
$3.50

CMRX.OQ

Chart for CMRX.OQ

About

Chimerix, Inc. (Chimerix) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral antivirals. The Company, based on its lipid conjugate technology, has developed its lead compound, brincidofovir (BCV, CMX001), which is in Phase III clinical development. In addition, the Company... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $224.17
Shares Outstanding(Mil.): 46.32
Dividend: --
Yield (%): --

Financials

  CMRX.OQ Industry Sector
P/E (TTM): -- 41.20 30.65
EPS (TTM): -2.15 -- --
ROI: -30.17 -0.59 15.23
ROE: -30.20 -1.31 16.56

BRIEF-Chimerix Q3 loss per share $0.37

* Chimerix inc- brincidofovir iv single and multiple dose data expected to report out in 2017

Nov 07 2016

BRIEF-Chimerix Q2 loss per share $0.39

* Q2 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

Aug 08 2016

Competitors

Earnings vs. Estimates